Hollings Cancer Center is committed to educating and providing exceptional training and mentoring opportunities to the next generation of scientists who will drive cancer discoveries in preventation, treatment and conrtol.
Cancer research career enhancement plays a critical role in developing and integrating cancer-focused research education, training and professional development activities across all levels.
As the only National Cancer Institute (NCI)-designated cancer in South Carolina, HCC's career enhancement mission focuses on three themes: providing innovative education and training opportunities, enhancing the diversity of the cancer research work force and supporting tracking and evaluation of education and training activities and programs. This is accomplished with the following aims:
Chanita Hughes-Halbert, Ph.D., HCC's associate director of Education and Training and co-leader of the Cancer Control Research Program, oversees the strategic planning, evaluation, and coordination of HCC’s career enhancement activities. Hughes-Halbert is an elected member of the National Academy of Medicine and a national investigator in cancer control. To guide, track and evaluate the various programs, Hughes-Halbert appointed an internal Education and Training Leadership Council comprising key members of HCC- and MUSC-sponsored professional development and career enhancement programs.
For undergraduate and graduate students interested in a career in biomedical sciences or cancer research, HCC offers several laboratory-based and cancer-focused courses to engage students.
Medical and graduate students can apply for cancer-focused programs through MUSC's Biomedical Sciences Doctoral Program, Medical Scientists Training Program and HCC's Fellowship Program.
Trainees interested in cancer research are encouraged to apply to participate in the Integrated Training in Oncogenic Signaling program as well as HCC's Postdoctoral & Clinical Fellowship Program.
To best foster the development of junior faculty, HCC offers training for clinical, basic and population based investigators as well as protected time for physician-scientists active in clinical cancer research.
In an effort to reach the entire state, HCC disseminates research information to the community and provide research education to health professionals and community-based health care providers.
Supported by the K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program, Dr. John Wrangle helped launch a clinical trial that resulted in a groundbreaking development for lung cancer treatment.